AstraZeneca, Samsung Biologics shut down joint venture – report



Samsung Biologics Co. has shut down its joint venture with pharmaceutical company AstraZeneca Plc, Yonhap News Agency reported citing a company official.

The two have decided to completely abandon th…

About the author:

Get involved!

Fai trading in gruppo!
L'unica Academy di trading completamente gratuita per gli utenti FpMarkets

Comments

Ancora nessun commento